Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px
Document › Details

Microsaic Systems plc. (10/21/13). "Press Release: Microsaic Systems Announces Prestigious New Scientific Advisory Group. High Profile Group Members Drawn from Research and Industry".

Organisations Organisation Microsaic Systems plc (AIM: MSYS)
  Organisation 2 BMSS (British Mass Spectrometry Society)
Products Product 4000 MiD® desktop MS system
  Product 2 mass spectrometry technology
Persons Person Jump, Colin (Dawes Scientific 201602– CEO at ETP before Microsaic CEO + Managing Director Shimadzu UK + SGE Europe)
  Person 2 Langley, G. John (Univ Southampton 201005 Head Mass Spectrometry)

Microsaic Systems plc (AIM: MSYS), the high technology company developing next-generation mass spectrometry instruments, announces the formation of its first Scientific Advisory Group. Colin Jump, CEO Microsaic Systems, commented, "With the successful international launch and showcasing of our premier product, the 4000 MiD, we have created a real interest in our growing portfolio of innovative chip-based technology. Moving forward we have now been able to draw on the extraordinary pool of expertise in the UK analysis and mass spectrometry arena to form a highly experienced Scientific Advisory Group. The members have impressive credentials across all areas of industry and research and will be able to advise us on realistic future applications for our chip-based technology."

The majority of the advisory group come from industry and research backgrounds, comprising the Chair: Dr Steve Lane, C.Chem, FRSC, Founder & Director of SJL Strategic Sciences and former Global VP Analytical Chemistry at GSK; Prof Frank Pullen, PhD, CSci, C.Chem, FRSC, Professor of Pharmaceutical Analysis, University of Greenwich and former Senior Director of Discovery Analytical Sciences at Pfizer, UK; Mr Richard Fussell, Senior Analytical Chemist in the Chemical Safety Programme of Food and Environment Research Agency (FERA); Dr Anthony Bristow, Associate Principal Scientist, Astra Zeneca and Chair BMSS; Dr Andrew Ray, Associate Principal Scientist, AstraZeneca; Dr John Langley, Head of Characterisation and Analytics, University of Southampton; Dr Neil Spooner, C.Chem, MRSC, Director, Bioanalytical Science & Development, PTS DMPK, GSK; Dr Donald Daley, Senior Director of DMPK & Physical Sciences, Argenta Discovery and former Department Director, Global Physical Chemistry and Structural Chemistry, Rhone Poulenc Rorer; and Prof Eric Yeatman, Director and co-founder of Microsaic Systems plc and Professor of Microengineering, Imperial College London. The remaining members are drawn from Microsaic's senior management: Mr Colin Jump, CEO; Mr Peter Edwards, Technical Director, Dr Steven Wright, Principal Scientist; and Mr Jeremy Reddish, Business Development Manager.

As well as helping to position Microsaic scientifically, the advisory group will advise on high impact areas of application for miniaturised MS and MS/MS and their efficient interfacing with separation front ends to help Microsaic understand the requirements for success in these application areas. The group will also consider the synergy between application and technology, defining the importance of the application and what technology /performance improvements are necessary to deliver miniaturised technology and help advise on opportunities for collaborative projects.

Record changed: 2016-01-10


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Microsaic Systems plc (AIM: MSYS)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioPharm America 2018 Boston September 600x60px

» top